top of page
David Jolley

Semaglutide: wonder drug which may reduce the incidence of dementia

I am not a supporter of the search for ‘The Silver Bullet’ which will prevent or cure Alzheimer’s disease.


Many millions of pounds have been spent on the search for a wonder drug which will protect or revive dying neurones – all to no avail. There is much more to be gained by applying what we know about life-style and general health to reduce the incidence of dementia, rather than the preference for a (money-spinning) magic potion.


But it is important to be flexible and open-minded. The week we are hearing about Semaglutamide which was developed as a treatment for Type-2 Diabetes: it works by binding to and activating glucagon-like peptide receptors to increase insulin secretion and suppress glucagon. It also slows gastric emptying.


Clinical observations found that patients who had been overweight, lost 10% or more of their body weight on this treatment. So it has become popular as a way of combating obesity even amongst people who do not have diabetes. Semaglutide for weight loss - what you need to know | UCLA Health


Now we read that Semaglutide may be effective in treating heart failure: Weight-loss drug can reverse heart failure symptoms, study finds | Heart disease | The Guardian


And there is a real possibility that it can reduce the incidence of dementia: Scientists hope weight-loss drugs could treat addiction and dementia | Dementia | The Guardian


Again the evidence comes from clinical observations of what happens when patients receive it as treatment for Type-2 diabetes. A study of 15,820 patients followed for a median 3.6 years found that only 15 developed dementia, compared with 32 in a control population. Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers - Nørgaard - 2022 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library


Careful clinical trials are now under way. There is cause for optimism.


One medication having multiple beneficial effects may make us suspicious – But aspirin has been long-established and is a truly wonder drug. We need to watch and wait, but this may be a new treatment that is worthwhile.









 




Each week we post a blog from David Jolley where he shares his personal views on relevant subjects.

3 views0 comments

Recent Posts

See All

Stress on spouse carers and child carers

At our most recent session of Dementia Conversations on line, discussion included thoughts on differences in the experiences of...

コメント


bottom of page